UBS raises Box stock price target to $37 on revenue acceleration

UBS raised its Box (BOX) price target to $37 from $29 while keeping a Neutral rating, citing undervaluation (fair value $36.14 vs. ~$33) and accelerating growth trends. Box reported fiscal Q2 revenue of $321.1M vs. $319.33M expected and adjusted EPS of $0.40 (in line), with net revenue retention improving to 106% and billings up 16% constant currency. The company’s second-half FY27 outlook implies revenue growth of 10–11% constant currency and billings growth of 8–9%, which UBS called conservative with upside potential tied partly to AI-driven traction.

Analysis

BOX is starting to look like a legitimate beneficiary of enterprise AI spend, but the market is no longer paying for the story alone. The key mechanism is not “AI hype” — it is whether AI features convert a mature installed base into higher net retention, more seats per account, and better mix on premium tiers. That supports revenue quality and can justify a modest premium to slower-growth infrastructure software, but after a strong multi-month move the stock is more likely to trade on proof of durability than on another target increase.

The second-order winner is the broader category of workflow software with embedded distribution: vendors that can bolt AI onto an existing customer relationship should get more credibility in coming quarters. The loser set is legacy content-management and document-workflow names that lack either data gravity or usage-based monetization; if BOX continues to show pricing uplift without churn, it raises the bar for peers that have been marketing “AI-enabled” products without measurable billings acceleration. The implication for the software basket is a widening split between application names with visible monetization and those relying on hope and maintenance revenue.

Risk is mostly a 1-3 month earnings/guidance setup, not a same-day event. The stock already embeds a lot of the good news, so any sign that second-half growth reverts toward low-double-digit or that billings momentum fades would likely trigger multiple compression quickly. Over 6-18 months, the real question is whether AI becomes a persistent seat-expansion engine or just a one-cycle upsell; if retention stalls below the mid-100s and RPO growth decelerates, the valuation case weakens materially. The contrarian point is that the conservative outlook may be more credible than the bullish sell-side interpretation: this may be a high-quality compounder, but not necessarily one that deserves aggressive multiple expansion from here.

Key Decisions for Investors

• Do not chase BOX after the recent rerating; wait for either a post-earnings reset or a pullback toward support before adding. Near current levels, upside looks modest versus downside if next quarter only meets guidance.
• If you need software beta exposure, pair long BOX vs short a legacy content/workflow peer basket (e.g., OTEX/DBX) over the next 1-3 months. Thesis: BOX has clearer AI monetization and better retention, while legacy names face proof-of-concept risk.
• For a relative-value expression, long BOX / short IGV on a market-neutral basis if the next earnings print confirms sustained billings and RPO momentum. This isolates idiosyncratic AI monetization from the broader software multiple.
• Set a downside alert if BOX loses its recent breakout level and management stops re-accelerating billings sequentially; that would be the first sign the AI contribution is being front-loaded rather than durable.
• If looking for a tactical trade, use a tight risk/reward structure rather than outright size: small long only on a pullback with a stop on billings deceleration, because the market is likely to punish any miss more than it rewards another modest beat.